Evidence map›Paper›PMID 23393142›Full record

ArticleThe Journal of biological chemistry2013

Synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases.

Kimberly A Malecka, Zsofia Szentpetery, Jeffrey R Peterson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Atg8-PE protein-basedAutophagy · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kimberly A MaleckaCancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Zsofia Szentpetery
Jeffrey R Peterson
Fox Chase Cancer Center · USNational Institutes of Health · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Specificity of Effector Activation by Rho Family GTPasesR01GM083025 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI PETERSON, JEFFREY R · 2008 to 2018
$3.2M
Intramural NIH HHSNCI NIH HHS P30 CA006927NCI NIH HHS T32 CA009035NIGMS NIH HHS GM083025NIGMS NIH HHS R01 GM083025
6 · The paper itself

Abstract

Autoinhibited p21-activated kinase 1 (Pak1) can be activated in vitro by the plasma membrane-bound Rho GTPases Rac1 and Cdc42 as well as by the lipid phosphatidylinositol (4,5)-bisphosphate (PIP2). Activator binding is mediated by a GTPase-binding motif and an adjacent phosphoinositide-binding motif. Whether these two classes of activators play alternative, additive, or synergistic roles in Pak1 activation is unknown, as is their contributions to Pak1 activation in vivo. To address these questions, we developed a system to mimic the membrane anchoring of Rho GTPases by creating liposomes containing both PIP2 and a Ni(2+)-NTA modified lipid capable of binding hexahistidine-tagged Cdc42. We find that among all biologically relevant phosphoinositides, only PIP2 is able to synergistically activate Pak1 in concert with Cdc42. Membrane binding of the kinase was highly sensitive to the spatial density of PIP2 and Pak1 demonstrated dramatically enhanced affinity for Cdc42 anchored in a PIP2 environment. To validate these findings in vivo, we utilized an inducible recruitment system to drive the ectopic synthesis of PIP2 on Golgi membranes, which normally have active Cdc42 but lack significant concentrations of PIP2. Pak1 was recruited to PIP2-containing membranes in a manner dependent on the ability of Pak1 to bind to both PIP2 and Cdc42. These findings provide a mechanistic explanation for the essential role of both phosphoinositides and GTPases in Pak1 recruitment and activation. In contrast, Ack, another Cdc42 effector kinase that lacks an analogous phosphoinositide-binding motif, fails to show the same enhancement of membrane binding and activation by PIP2, thus indicating that regulation by PIP2 and Cdc42 could provide a combinatorial code for activation of different GTPase effectors in different subcellular locations.

Indexed as

Gene Expression Regulation, EnzymologicAmino Acid MotifsBinding Sitescdc42 GTP-Binding ProteinCell MembraneDose-Response Relationship, DrugEnzyme ActivationGolgi ApparatusHEK293 CellsHumansLiposomesNickelp21-Activated KinasesPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphotransferases (Alcohol Group Acceptor)1-phosphatidylinositol-4-phosphate 5-kinasecdc42 GTP-Binding ProteinLiposomesNickelp21-Activated KinasesPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphotransferases (Alcohol Group Acceptor)rac1 GTP-Binding ProteinRAC1 protein, humanrho GTP-Binding ProteinsSirolimus

Identifiers

PMID23393142
PMCPMC3610963
OpenAlexW2075388057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.